Catalyst Wire Dossier Catalyst Wire Dossier

CAR T cell immunotherapy

Chimeric antigen receptor T-cell therapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR T cell immunotherapy, covering 2025-06-17 to 2025-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia [Phase 1]

See pricing